According to the National Institute of Health, autosomal dominant polycystic kidney disease (ADPKD) affects 1 in every 400 to 1,000 people globally. Polycystic kidney disease (PKD) is among the most prevalent genetic disorders, impacting around 500,000 people in the United States. Polycystic Kidney Disease Drug Pipeline Analysis There is an increa